DOI:

How does inflammation influence left ventricular function after TAVI?

Vavuranakis M., Kariori M., Aznaouridis K., Moldovan C., Vrachatis D., Kalogeras K., Stefanadis C.

Pot-pourri

How does inflammation influence left ventricular function after TAVI?

Aims: Transcatheter aortic valve implantation (TAVI) is an emerging treatment option for inoperable or high-risk patients. After the procedure, most patients show significant improvement of left ventricular function. However, the recovery of the left ventricle is not immediately observed in all patients, while in some there is a temporary deterioration. Furthermore, elevated levels of CRP and white blood cells (WBC) are observed in some patients after TAVI. Elevated CRP has been associated with reduced left ventricular function. Therefore, we hypothesised that inflammatory parameters may influence left ventricular recovery after TAVI.

Methods and results: Data from 76 consecutive patients (80.37±5.36 years, 33 males (48.8%), AVA: 0.63±0.15 cm2) who underwent TAVI were evaluated from an existing database. Blood samples were obtained before TAVI, three hours and daily for five days after the procedure. CRP as well as WBC were recorded. In addition, transthoracic echocardiogram was performed and obtained before TAVI and daily for five days after the procedure. Patients were separated into three groups according to left ventricle improvement (improved, declined, unaffected). From these groups, LVEF improved in 29 patients (39.7%), declined in 11 patients (15.1%) and remained unaffected in 33 patients (45.2%). We performed the ANOVA statistical test among the three groups and found significant differences between them for CRPmax (p<0.01) and WBC1st day after (p<0.01). In particular, post hoc analysis showed higher levels of CRPmax (70.2±49.28 vs. 120±22.36, p<0.01) and WBC1st day after (16,333±4,685 vs. 11,748±3,512, p<0.01) in patients with declined LVEF compared to those with unaffected LVEF, respectively. Similarly, post hoc analysis recorded greater value for CRPmax (120±22.36 vs. 61.99±36.9, p<0.01) and WBC1st day after (16,528±4,890 vs. 10,800±2,687, p<0.01) in patients with declined LVEF when compared with those with improved LVEF.

Conclusions: In conclusion, inflammation as detected by simple indices such as WBC and CRP may be associated with left ventricular function after TAVI.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00068 Mar 4, 2024
Acute changes in microvascular resistance after treating aortic stenosis
Johnson N and Eerdekens R
free

Clinical research

10.4244/EIJ-D-22-00817 Jun 19, 2023
Impact of early changes in cardiac damage following transcatheter aortic valve implantation
Zhou Y et al
free

CLINICAL RESEARCH

10.4244/EIJY15M02_02 Apr 20, 2016
The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation
Sinning J et al
free
Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved